- Home
- SPGI vs BMY Comparison
SPGI vs BMY Comparison
Compare SPGI & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPGI
- BMY
- Stock Information
- Founded
- SPGI 1860
- BMY 1887
- Country
- SPGI United States
- BMY United States
- Employees
- SPGI N/A
- BMY N/A
- Industry
- SPGI Finance: Consumer Services
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- SPGI Finance
- BMY Health Care
- Exchange
- SPGI Nasdaq
- BMY Nasdaq
- Market Cap
- SPGI 142.3B
- BMY 120.5B
- IPO Year
- SPGI N/A
- BMY N/A
- Fundamental
- Price
- SPGI $507.61
- BMY $46.44
- Analyst Decision
- SPGI Strong Buy
- BMY Hold
- Analyst Count
- SPGI 15
- BMY 16
- Target Price
- SPGI $588.43
- BMY $58.93
- AVG Volume (30 Days)
- SPGI 1.2M
- BMY 16.4M
- Earning Date
- SPGI 04-29-2025
- BMY 04-24-2025
- Dividend Yield
- SPGI 0.76%
- BMY 5.34%
- EPS Growth
- SPGI 42.93
- BMY N/A
- EPS
- SPGI 12.73
- BMY 2.67
- Revenue
- SPGI $14,494,000,000.00
- BMY $47,636,000,000.00
- Revenue This Year
- SPGI $7.59
- BMY N/A
- Revenue Next Year
- SPGI $7.24
- BMY N/A
- P/E Ratio
- SPGI $39.90
- BMY $17.39
- Revenue Growth
- SPGI 12.99
- BMY 4.62
- 52 Week Low
- SPGI $419.49
- BMY $39.35
- 52 Week High
- SPGI $545.39
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- SPGI 60.49
- BMY 30.27
- Support Level
- SPGI $500.07
- BMY $48.69
- Resistance Level
- SPGI $514.78
- BMY $50.65
- Average True Range (ATR)
- SPGI 10.26
- BMY 1.36
- MACD
- SPGI 4.07
- BMY 0.04
- Stochastic Oscillator
- SPGI 88.88
- BMY 2.66
About SPGI S&P Global Inc.
S&P Global provides data and benchmarks to capital and commodity market participants. Its ratings business is the largest credit rating agency in the world and S&P's largest segment by profitability. S&P's largest segment by revenue is market intelligence, which provides desktop, data and advisory solutions, enterprise solutions, and credit/risk solutions mostly in the financial-services industry. S&P's other segments include commodity insights (Platts and other data), mobility (Carfax), and indexes.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.